Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers
- PMID: 19053167
- PMCID: PMC2935779
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers
Abstract
The expanding and established literature that correlates tumor infiltrating lymphocytes (TILs) with outcomes of patients with solid tumors has contributed greatly to the appreciation of the interaction between the host immune system with neoplastic growth. This analysis has been limited to specific tumors, such as melanoma and ovarian cancer, and our understanding of TILs in relation to many other malignancies has yet to be explored. We review one less well studied malignancy, head and neck squamous cell carcinoma (HNSCC), and the initial attempts to examine the impact of TILs on outcomes of these patients. To provide a context for the discussion of TILs and HNSCC, we first review the epidemiology, relevant head and neck anatomy, immune responses and discuss the historical data regarding the unique immunobiology of these tumors. Finally, with this perspective, we describe our current understanding of tumor infiltrating lymphocyte data for head and neck cancers.
Figures
Similar articles
-
TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?Head Neck Pathol. 2017 Sep;11(3):354-363. doi: 10.1007/s12105-016-0776-8. Epub 2016 Dec 28. Head Neck Pathol. 2017. PMID: 28032290 Free PMC article. Review.
-
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.Adv Anat Pathol. 2017 Nov;24(6):311-335. doi: 10.1097/PAP.0000000000000161. Adv Anat Pathol. 2017. PMID: 28777143 Free PMC article. Review.
-
Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice.Acta Otolaryngol. 2020 Mar;140(3):246-248. doi: 10.1080/00016489.2020.1720284. Epub 2020 Feb 5. Acta Otolaryngol. 2020. PMID: 32022615 Review.
-
Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors.Cancer Immunol Immunother. 2020 Apr;69(4):581-591. doi: 10.1007/s00262-020-02481-3. Epub 2020 Jan 24. Cancer Immunol Immunother. 2020. PMID: 31980916 Free PMC article.
-
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.Head Neck. 2016 Jul;38(7):1074-84. doi: 10.1002/hed.24406. Epub 2016 Feb 16. Head Neck. 2016. PMID: 26879675 Free PMC article.
Cited by
-
High PD-L1 expression on immune cells along with increased density of tumor-infiltrating lymphocytes predicts a favorable survival outcome for patients with loco-regionally advanced head and neck cancer: early results from a prospective study.Front Oncol. 2024 Apr 4;14:1346793. doi: 10.3389/fonc.2024.1346793. eCollection 2024. Front Oncol. 2024. PMID: 38638854 Free PMC article.
-
Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma.Sci Prog. 2024 Jan-Mar;107(1):368504241237888. doi: 10.1177/00368504241237888. Sci Prog. 2024. PMID: 38545800 Free PMC article. Review.
-
Programmed Cell Death Ligand 1 Expression on Immune Cells and Survival in Patients With Nonmetastatic Head and Neck Cancer: A Systematic Review and Meta-analysis.JAMA Netw Open. 2023 Mar 1;6(3):e236324. doi: 10.1001/jamanetworkopen.2023.6324. JAMA Netw Open. 2023. PMID: 37000447 Free PMC article.
-
KIF11 As a Potential Pan-Cancer Immunological Biomarker Encompassing the Disease Staging, Prognoses, Tumor Microenvironment, and Therapeutic Responses.Oxid Med Cell Longev. 2022 Dec 16;2022:2764940. doi: 10.1155/2022/2764940. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36742345 Free PMC article.
-
Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer.BMC Cancer. 2023 Feb 1;23(1):113. doi: 10.1186/s12885-023-10576-0. BMC Cancer. 2023. PMID: 36726072 Free PMC article.
References
-
- Clark WH Jr, Elder DE, Guerry D 4th, Braitman LE, Trock BJ, Schultz D, Synnestvedt M, Halpern AC. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989;81:1893–1904. - PubMed
-
- Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer. 1996;77:1303–1310. - PubMed
-
- Deyrup AT. Epstein-Barr virus-associated epithelial and mesenchymal neoplasms. Hum Pathol. 2008;39:473–483. - PubMed
-
- Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365:2041–2054. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical